Computer-based Intervention for Alcohol-using HIV/HCV+ Women
Completed · Not applicable
Conditions studied: Human Immunodeficiency Virus, Hepatitis C, Alcohol Abuse
In brief
The study harnessed the multidisciplinary expertise of our research team to develop a brief, computer-based, alcohol reduction intervention tailored for HIV/HCV co-infected women and evaluate its efficacy. The intervention, if effective, may be an efficient and cost-effective alcohol reduction strategy, that is scalable and can be readily disseminated and integrated in clinical care at other AIDS Centres in Russia to enhance women's health and reduce HIV/HCV transmission risk.
Key facts
- Study ID
- NCT03362476
- Run by
- New York University
- People needed
- 200
- Starts
- 2018-01-03
- Expected to finish
- 2022-02-28
- Last updated by the study team
- 2025-01-09
Who can join
Age: 21 and older, up to 45. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- female;
- receiving HIV medical care at the AIDS Center;
- chart-documented HIV and chronic HCV infection;
- currently prescribed an antiretroviral (ARV) regimen;
- medically, cognitively, and psychologically capable of study participation;
- laboratory-confirmed recent alcohol use as detected by a Ethylglucuronide (EtG) analysis or self-reported alcohol use
You may not qualify if…
- not identifying as biological female
- not HIV and HCV positive
- no laboratory-confirmed or self-reported
- not willing to participate in the trial
- not able to participate in the trial due to medical, cognitive, or psychological issues
Where it is running
- New York University — New York, New York, United States
- North West District AIDS Center — Saint Petersburg, Russia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.